Sidebar is Loading...
Loading...
Brands
Resources
YSTV
ADVERTISEMENT
Loading...
Brands
Resources
YSTV
Dognosis develops breath-based diagnostic tools for early disease detection, starting with cancer.
Dognosis is an Indian deep-tech health technology startup developing AI-powered, non-invasive disease detection solutions by combining the extraordinary olfactory abilities of trained dogs with brain-computer interface (BCI) technology and machine learning. Its proprietary platform, comprising DogSense (a canine BCI) and DogOS (an AI-powered analytics platform), translates canine scent detection into digital signals for accurate disease screening. The company's flagship solution, BreathEasy, is a breath-based multi-cancer early detection (MCED) test that analyzes volatile organic compounds (VOCs) associated with disease. By integrating canine intelligence with advanced AI, Dognosis aims to provide an affordable, scalable, and highly accurate screening tool for early disease detection, helping improve patient outcomes through earlier diagnosis.
Total Funding
$2.0M
Investors
:
1.
Prosus Ventures
2.
Boost VC
3.
Accel Atoms
TraceX Labs is a cybersecurity company that develops software-as-a-service (SaaS) security platforms designed to detect and analyze digital threats. The company specializes in AI-driven enterprise cyber defense, threat intelligence, mobile threat detection, and risk management, focusing on building technologies that help organizations identify cyber risks across web platforms, mobile devices, and enterprise networks.
Frequently Asked Questions
TraceX Labs is a cybersecurity company that develops software-as-a-service (SaaS) security platforms designed to detect and analyze digital threats. The company specializes in AI-driven enterprise cyber defense, threat intelligence, mobile threat detection, and risk management, focusing on building technologies that help organizations identify cyber risks across web platforms, mobile devices, and enterprise networks.
